Association between mood-stabilizing medication and mental health resource use in the management of acute mania

Psychiatric Services

Volumn 48, Issue 8, 1997, Pages 1037-1041

  Sajatovic, Martha ^a,b   Gerhart, Connie ^a   Semple, William ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; LITHIUM; NEUROLEPTIC AGENT; TRANQUILIZER; VALPROIC ACID;

ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PATIENT COMPLIANCE;

EID: 0030811186     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.48.8.1037     Document Type: Article

References (30)

1. Pope HG Jr, McElroy SL, Keck PE Jr: Valproate in acute mania: a controlled trial. Archives of General Psychiatry 48:62-68, 1991
2. Small JG: Anticonvulsants in affective disorders. Psychopharmacology Bulletin 26: 25-36, 1990
3. Price LH, Heninger GR: Lithium in the treatment of mood disorder. New England Journal of Medicine 331:591-598, 1994
4. Practice guidelines for the treatment of patients with bipolar disorder. American Journal of Psychiatry 151(Dec suppl), 1994
5. Freeman TW, Clothier JL, Pazzaglia P, et al: A double-blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry 149: 108-111, 1992
6. Chouinard G, Young SN, Annable L: Antimanic effect of clonazepam. Biological Psychiatry 18:451-466, 1983
7. Freinhar JP Alvarez WH: Use of clonazepam in two cases of acute mania. Journal of Clinical Psychiatry 46:29-30, 1985
8. Bowden CL: Depakote mania study group: efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 271:918-924, 1994
9. Small JG, Klapper M, Milstein V, et al: Carbamazepine compared to lithium in the treatment of mania. Archives of General Psychiatry 48:915-921, 1991
10. Gerner RH, Stanton A: Algorithm for patient management of acute manic states: lithium, valproate, or carbamazepine? Journal of Clinical Psychopharmacology 12(suppl 1):57S-63S, 1992
11. Bowden CL: Predictors of response to divalproex sodium. Journal of Clinical Psychiatry 56(suppl 3):3-5, 1995
12. Sovner R: The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders. Journal of Clinical Psychiatry 50(suppl 3):40-43, 1989
13. Kahn D, Stevenson E, Douglas CJ: Effect of sodium valproate in three patients with organic brain syndrome. American Journal of Psychiatry 145:1010-1011, 1988
14. Keck PE, Nabulsi AA, Taylor JL, et al: A pharmacoeconomic model of divalproex vs lithium in the acute and prophylactic treatment of bipolar I disorder. Journal of Clinical Psychiatry 57:213-222, 1996
15. Frye MA, Altshuler LL, Szuba MR et al: The relationship between antimanic agents for treatment of classic or dysphoric mania and length of hospital stay. Journal of Clinical Psychiatry 57:17-21, 1996
16. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, rev. Washington, DC, American Psychiatric Association, 1987
17. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990
18. Bowden CL: The efficacy of divalproex sodium and lithium in the treatment of acute mania. Psychiatry Forum, no 16, 1996, pp i-vi
19. Stall AL, Locke CA, Vuckovic A, et al: Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: a case series. Journal of Clinical Psychiatry 57:356-359, 1996
20. Kashner TM, Rader LE, Rodell DE, et al: Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Hospital and Community Psychiatry 42:195-197, 1991
21. Bartels SJ, Teague GB, Drake RE, et al: Substance abuse in schizophrenia: service utilization and cost. Journal of Nervous and Mental Disease 181:227-232, 1993
22. Sonne SC, Brady KT, Morton WA: Substance abuse and bipolar affective disorder. Journal of Nervous and Mental Disease 182:349-352, 1994
23. Brady KT, Lydiard RB: Bipolar affective disorder and substance abuse. Journal of Clinical Psychopharmacology 12(suppl 1):17S-22S, 1992
24. Keck PE, McElroy SL, Tugral KC, et al: Valproate oral loading in the treatment of acute mania. Journal of Clinical Psychiatry 54:305-308, 1993
25. Post RM, Rubinow DR, Ballenger JC: Conditioning and sensitization in the longitudinal course of affective illness. British Journal of Psychiatry 149:191-201, 1986
26. Licht RW, Gouliaev G, Vestergard P, et al: Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. Journal of Affective Disorders 32:179-185, 1994
27. Sernyak MJ, Griffen RA, Johnson RM, et al: Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. American Journal of Psychiatry 151:133-135, 1994
28. Kane JM, Smith JM: Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Archives of General Psychiatry 39:473-481, 1982
29. McElroy SL, Keck PE, Stanton SP et al: A randomized comparison of divalproex oral loading dose versus haloperidol in the initial treatment of acute psychotic mania. Journal of Clinical Psychiatry 57:142-146, 1996
30. Keck PE, McElroy SL, Strowkowski SM, et al: Factors associated with pharmacologic noncompliance with mania. Journal of Clinical Psychiatry 57(7):292-297, 1996